Aurinia Pharmaceuticals Inc.
AUPH
$12.27
$0.191.57%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.84% | 1,533.59% | -90.04% | 1,887.53% | 106.72% |
| Total Depreciation and Amortization | 0.16% | -0.12% | -0.63% | 1.03% | -0.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 729.51% | -243.56% | -86.35% | 91.36% | 365.68% |
| Change in Net Operating Assets | 122.93% | -211.09% | 286.53% | -334.61% | 147.74% |
| Cash from Operations | 3,303.15% | -95.68% | 76.84% | 7.49% | 185.19% |
| Capital Expenditure | -476.47% | 93.95% | -- | -- | -966.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -142.43% | -21.40% | 473.67% | 72.54% | -178.17% |
| Cash from Investing | -142.77% | -20.88% | 471.01% | 72.63% | -178.45% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -23.78% | 8.55% | -2.43% | 8.22% | -16.02% |
| Issuance of Common Stock | -81.66% | 17.24% | 3,256.78% | -82.03% | -76.23% |
| Repurchase of Common Stock | 23.61% | -99.92% | -- | 100.00% | 64.25% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 10.02% | -114.08% | -746.66% | 67.10% | 45.03% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 21.05% | -136.74% | 1,139.38% | 112.03% | -299.26% |